Hypophosphatemia - Revision history

Danbot: Add References

2026-03-22T09:36:20Z

Add References

← Older revision		Revision as of 09:36, 22 March 2026
Line 78:		Line 78:
	==See Also==		==See Also==
	*[[Electrolyte Abnormalities (Main)]]		*[[Electrolyte Abnormalities (Main)]]

			==References==
			<references/>

	[[Category:FEN]]		[[Category:FEN]]

ClaireLewis: /* Differential Diagnosis */

2019-10-16T16:48:51Z

Differential Diagnosis

← Older revision		Revision as of 16:48, 16 October 2019
Line 33:		Line 33:
	**Acute volume expansion		**Acute volume expansion
	**Intravenous [[iron supplementation\|iron administration]]		**Intravenous [[iron supplementation\|iron administration]]
	*Renal replacement therapy ([[dialysis]])		*Renal replacement therapy ([[dialysis complications\|dialysis]])

	==Evaluation==		==Evaluation==

ClaireLewis at 16:14, 29 September 2019

2019-09-29T16:14:49Z

← Older revision		Revision as of 16:14, 29 September 2019
Line 5:		Line 5:
	*CNS		*CNS
	**[[Weakness]]		**[[Weakness]]
	**Circumoral and fingertip paresthesias		**Circumoral and fingertip [[paresthesias]]
	**Decreased DTRs		**Decreased DTRs
	**[[Decreased Mental Status]]		**[[Decreased Mental Status]]
Line 14:		Line 14:
	===Causes of Hypophosphatemia===		===Causes of Hypophosphatemia===
	*Internal redistribution		*Internal redistribution
	**Refeeding of malnourished		**[[refeeding syndrome\|Refeeding of malnourished]]
	**[[DKA]]		**[[DKA]]
	**[[Nonketotic hyperglycemia]]		**[[Nonketotic hyperglycemia]]
Line 29:		Line 29:
	**[[Fanconi syndrome]]		**[[Fanconi syndrome]]
	***[[Multiple myeloma]]		***[[Multiple myeloma]]
	**Osmotic diuresis (most often due to glucosuria)		**Osmotic diuresis (most often due to [[hyperglycemia\|glucosuria]])
	**Proximally acting diuretics (e.g. [[acetazolamide]] and some [[thiazide diuretics]])		**Proximally acting [[diuretics]] (e.g. [[acetazolamide]] and some [[thiazide diuretics]])
	**Acute volume expansion		**Acute volume expansion
	**Intravenous iron administration		**Intravenous [[iron supplementation\|iron administration]]
	*Renal replacement therapy (dialysis)		*Renal replacement therapy ([[dialysis]])

	==Evaluation==		==Evaluation==
Line 56:		Line 56:
	*NOT able to take PO		*NOT able to take PO
	**Minimize or eliminate all dextrose-containing IV solutions		**Minimize or eliminate all dextrose-containing IV solutions
	**Aggressively treat acidosis		**Aggressively treat [[acidosis]]
	**Give 15 mmol of IV potassium phosphate over 2.5 hours (contains 22 mEq K)		**Give 15 mmol of IV potassium phosphate over 2.5 hours (contains 22 mEq K)
	***Peripheral administration may cause burning at injection site		***Peripheral administration may cause burning at injection site
Line 63:		Line 63:

	'''Serum phosphate <1mg/dl'''		'''Serum phosphate <1mg/dl'''
	*Minimize or eliminate all dextrose-containing IV solutions		*Minimize or eliminate all [[dextrose]]-containing IV solutions
	**Exceptions: vasopressors, sedatives, analgesics, antibiotics, blood products, NS		**Exceptions: vasopressors, sedatives, analgesics, antibiotics, blood products, NS
	*Aggressively treat acidosis		*Aggressively treat [[acidosis]]
	*Give 45 mmol of IV potassium phosphate over 7 hours (contains 66 mEq of K)		*Give 45 mmol of IV potassium phosphate over 7 hours (contains 66 mEq of K)
	**Peripheral administration may cause burning at injection site		**Peripheral administration may cause burning at injection site

Rossdonaldson1: /* See Also */

2017-01-21T22:41:14Z

Rossdonaldson1: /* Management */

2017-01-21T22:40:53Z

Management

← Older revision		Revision as of 22:40, 21 January 2017
Line 41:		Line 41:

	==Management==		==Management==
	*Mild-~~mod~~		*Mild-moderate
	**KPhos /neutra phos PO		**KPhos /neutra phos PO
	*Severe		*Severe

Rossdonaldson1: /* Evaluation */

2017-01-21T22:40:45Z

Evaluation

← Older revision		Revision as of 22:40, 21 January 2017
Line 37:		Line 37:
	==Evaluation==		==Evaluation==
	*2.5-2.8 Mild		*2.5-2.8 Mild
	*1.0-2.5 ~~Mod~~		*1.0-2.5 Moderate
	*<1.0 Severe		*<1.0 Severe

Neil.m.young: Text replacement - "==Diagnosis==" to "==Evaluation=="

2016-07-24T15:41:17Z

Text replacement - "==Diagnosis==" to "==Evaluation=="

← Older revision		Revision as of 15:41, 24 July 2016
Line 35:		Line 35:
	*Renal replacement therapy (dialysis)		*Renal replacement therapy (dialysis)

	==~~Diagnosis~~==		==Evaluation==
	*2.5-2.8 Mild		*2.5-2.8 Mild
	*1.0-2.5 Mod		*1.0-2.5 Mod

Neil.m.young: Text replacement - "2 mg" to "2mg"

2016-07-21T06:38:35Z

Text replacement - "2 mg" to "2mg"

← Older revision		Revision as of 06:38, 21 July 2016
Line 47:		Line 47:

	===Harbor UCLA Adult Treatment Guidelines===		===Harbor UCLA Adult Treatment Guidelines===
	'''Serum phosphate 1mg/dl to ~~2 mg~~/dl'''		'''Serum phosphate 1mg/dl to 2mg/dl'''
	*Able to take PO		*Able to take PO
	**Minimize or eliminate all dextrose-containing IV solutions		**Minimize or eliminate all dextrose-containing IV solutions
Line 53:		Line 53:
	**1 tab K-phos neutral 250mg Q hour x 5 doses		**1 tab K-phos neutral 250mg Q hour x 5 doses
	***Each tab contains phosphorus 8 mmol, Na 13 mEq, K1.1 mEq		***Each tab contains phosphorus 8 mmol, Na 13 mEq, K1.1 mEq
	**Recheck serum phosphate after last dose, and repeat dosing if continues to be <~~2 mg~~/dl		**Recheck serum phosphate after last dose, and repeat dosing if continues to be <2mg/dl
	*NOT able to take PO		*NOT able to take PO
	**Minimize or eliminate all dextrose-containing IV solutions		**Minimize or eliminate all dextrose-containing IV solutions
Line 60:		Line 60:
	***Peripheral administration may cause burning at injection site		***Peripheral administration may cause burning at injection site
	***Consider central venous administration, if available		***Consider central venous administration, if available
	***Repeat dosing regimen if serum phosphate remains <~~2 mg~~/dl		***Repeat dosing regimen if serum phosphate remains <2mg/dl

	'''Serum phosphate <1mg/dl'''		'''Serum phosphate <1mg/dl'''
Line 72:		Line 72:
	*Recheck serum phosphate after infusion		*Recheck serum phosphate after infusion
	**Repeat IV administration if <1mg/dl		**Repeat IV administration if <1mg/dl
	**Consider oral administration if >1mg and <~~2 mg~~/dl		**Consider oral administration if >1mg and <2mg/dl

	==See Also==		==See Also==

Neil.m.young: Text replacement - "5 mg" to "5mg"

2016-07-20T09:10:54Z

Text replacement - "5 mg" to "5mg"

← Older revision		Revision as of 09:10, 20 July 2016
Line 44:		Line 44:
	**KPhos /neutra phos PO		**KPhos /neutra phos PO
	*Severe		*Severe
	**KPhos 2.5-~~5 mg~~/kg IV over 6hr		**KPhos 2.5-5mg/kg IV over 6hr

	===Harbor UCLA Adult Treatment Guidelines===		===Harbor UCLA Adult Treatment Guidelines===

Neil.m.young: Text replacement - "1 mg" to "1mg"

2016-07-19T07:51:47Z

Text replacement - "1 mg" to "1mg"

← Older revision		Revision as of 07:51, 19 July 2016
Line 47:		Line 47:

	===Harbor UCLA Adult Treatment Guidelines===		===Harbor UCLA Adult Treatment Guidelines===
	'''Serum phosphate ~~1 mg~~/dl to 2 mg/dl'''		'''Serum phosphate 1mg/dl to 2 mg/dl'''
	*Able to take PO		*Able to take PO
	**Minimize or eliminate all dextrose-containing IV solutions		**Minimize or eliminate all dextrose-containing IV solutions
Line 62:		Line 62:
	***Repeat dosing regimen if serum phosphate remains <2 mg/dl		***Repeat dosing regimen if serum phosphate remains <2 mg/dl

	'''Serum phosphate <~~1 mg~~/dl'''		'''Serum phosphate <1mg/dl'''
	*Minimize or eliminate all dextrose-containing IV solutions		*Minimize or eliminate all dextrose-containing IV solutions
	**Exceptions: vasopressors, sedatives, analgesics, antibiotics, blood products, NS		**Exceptions: vasopressors, sedatives, analgesics, antibiotics, blood products, NS
Line 71:		Line 71:
	*If patient can tolerate PO, ALSO follow steps 1 above		*If patient can tolerate PO, ALSO follow steps 1 above
	*Recheck serum phosphate after infusion		*Recheck serum phosphate after infusion
	**Repeat IV administration if <~~1 mg~~/dl		**Repeat IV administration if <1mg/dl
	**Consider oral administration if >1mg and <2 mg/dl		**Consider oral administration if >1mg and <2 mg/dl

← Older revision		Revision as of 22:41, 21 January 2017
Line 73:		Line 73:
	**Repeat IV administration if <1mg/dl		**Repeat IV administration if <1mg/dl
	**Consider oral administration if >1mg and <2mg/dl		**Consider oral administration if >1mg and <2mg/dl

			==Disposition==

	==See Also==		==See Also==